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Abstract Bacterial cell envelope is generally accepted as the
primary target for a photo-induced oxidative stress. It is plau-
sible that DNA damage occurs during the antimicrobial
photoinactivation. Here we investigate the correlation be-
tween DNA damage and photoinactivation by evaluating the
level of RecA-based DNA repair system in Staphylococcus
aureus. By using exogenous photosensitizers (new methylene
blue (NMB), toluidine blue O (TBO), 5,10,15,20-tetrakis(1-
methyl-4-pyridinio)porphyrin tetra(p-toluenesulfonate)
(TMPyP), zinc phthalocyanine (ZnPc), Rose Bengal (RB))
and ALA-induced endogenous porphyrin-dependent blue
light (405 nm), several outcomes were observed: (i) an in-
crease of DNA damage (from gel electrophoresis in DNA
damage assay), (ii) an increase of recA expression (lumines-
cence assay in recA-lux strain), and (iii) an increase of RecA
protein level (Western blotting). When recA expression was
repressed by novobiocin, or abolished by deleting the gene, S.
aureus susceptibility towards photoinactivation was increased
at approximately a hundred-fold. The absence of RecA in-
creases DNA damage to yield bactericidal effect. In
novobiocin-resistant mutant (gyrB), as opposed to wild type,
neither RecA protein level nor cell’s susceptibility was affect-
ed by photoinactivation (when novobiocin is present). This is
to suggest that GyrB-dependent inhibition mediated recA re-
pression. Therefore, we have established the role of RecA in
DNA damage during photoinactivation.With the use of rifam-
picin mutation frequency and Ames tests, we demonstrated
that photoinactivation did not increase S. aureus mutagenesis
and potentially is not mutagenic toward eukaryotic cells. The
results suggest that the treatment is considered safe. In con-
clusion, we provide an evidence that recA inhibitor may serve
as therapeutic adjuvant for antimicrobial photoinactivation.
Clinical relevance of our findings warrants further
investigations.
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Introduction
Photoinactivation is one of the twentieth century’s antimicro-
bial discovery strategies against antibiotic-resistant pathogens,
such as Staphylococcus aureus, by using three principle ele-
ments: photosensitizer (PS), visible light, and oxygen. In the
presence of molecular oxygen and visible light, PS leads to the
irreversible damage of various cell components (cell enve-
lopes, lipids, proteins, and DNA) (Girotti 2001). With unspe-
cific molecular targets, it is unlikely for bacteria to develop
resistance against photodynamic processes. This approach is
also called photodynamic inactivation (PDI), or antimicrobial
photodynamic therapy (aPDT), and is being considered as a
promising alternative for the treatment of localized infections
(Yin et al. 2013). Several chemical classes of PSs that are
evaluated against antimicrobial resistant bacteria upon illumi-
nation are (i) phenothiazines (new methylene blue, NMB;
toluidine blue O, TBO), (ii) tetrapyrrolic macrocycles such
as porphyr ins (5 ,10 ,15 ,20 - te t r ak i s (1 -methy l -4 -
pyridinio)porphyrin tetra(p-toluenesulfonate), TMPyP), (iii)
phthalocyanines (zinc phthalocyanine, ZnPc), (iv) xanthene
dyes (Rose Bengal, RB), and (v) fullerenes (Kasimova et al.
2014; Quiroga et al. 2012; Mantareva et al. 2011; Kato et al.
2012; Grinholc et al. 2015). However, PDI can also be done
using only blue light treatment with wavelengths of 405 or
470 nm in the presence of endogenous PS (Maclean et al.
2014; Rossi et al. 2012). PDI is a result of electron transfer,
or energy transfer, from the light to its surroundings. During
illumination, the PS in the ground state absorbs a photon and
reaches an excited singlet state. Subsequently, during the
course of losing energy, it returns to the ground state or can
be converted into an excited triplet state. In this state, energy
can be transferred to the surrounding substrates (type I) or to
ground state molecular oxygen (type II), depending on the
reaction type. Type I and type II reactions produce reactive
oxygen species and excited singlet state oxygen, respectively.
Both forms of reactive oxygen can cause two major cellular
damages: the destruction of cell membranes and organelles
and DNA damage (Foote 1991; Alves et al. 2014). The cell
is protected by DNA repair systems; therefore, DNA damage
may not be themain cause of cell death. The promising feature
of PDI is to combat S. aureus, which may be improved by
controlling DNA repair system, i.e., eliminating or inhibiting
the expression of recA.
It is generally accepted that membrane proteins and other
constituents of cell envelopes are major targets of photody-
namic oxidation, even though some sensitizers can bind to
DNA (Alves et al. 2014). Moreover, the photocleavage of
bacterial DNA is considered to occur only when cells are
largely photoinactivated or are no longer viable (Alves et al.
2014). If it was the case, the inhibition of the bacterial DNA
repair system should not increase the photoinactivation effica-
cy. Current study shows that the bactericidal effectiveness of
photoinactivation can be enhanced in the recA-negative strain
or using an agent that downregulates recA, such as the
aminocoumarin antibiotic agent novobiocin.
DNA damage triggers the SOS response, which is an in-
ducible pathway for DNA repair. Two key proteins are in-
volved in the SOS response: LexA (repressor) and RecA (in-
ducer). In the absence of DNA damage, LexA binds to DNA
to repress the transcription of several genes that are involved
in DNA repair and cell division (16 genes in the case of S.
aureus), including lexA and recA (Cirz et al. 2007). In re-
sponse to DNA damage, the coprotease function of RecA is
activated by binding to single-stranded DNA (ssDNA) and the
formation of a nucleoprotein filament. RecA promotes the
self-cleavage of LexA, leading to the derepression of SOS
genes (Butala et al. 2009).
In previous reports, the recA expression was known to be
activated by several classes of antibiotics, including
fluoroquinolones, such as ciprofloxacin and inhibited by
aminocoumarins (i.e., novobiocin) (Mesak et al. 2008;
Schroder et al. 2013). In this study, the importance of DNA
repair system in PDI was analyzed using (i) S. aureus HG001
recA and HG001 lexAG94E (Schroder et al. 2013), (ii)
novobiocin-resistant S. aureus HG001 nov142 (Schroder
et al. 2014), and (iii) S. aureus promotor-lux constructs (recA-
lux and lexA-lux) (Mesak et al. 2008). The use of these strains
has supported the contribution of DNA damage to the efficacy
of PDI.
In the present work, we explored whether DNA damage
occurs during the PDI process and inhibition of the RecA-
dependent DNA repair system could increase the treatment
efficacy. We found out that photodynamic treatment elevated
the expression of recA and RecA. Moreover, inactivation of
recA reduced the viability of S. aureus following photody-
namic treatment. Since photo-generated oxidative stress and
the resultant DNA damage could induce bacterial mutagenesis
(Kohanski et al. 2010), we also explored the mutagenic activ-
ity and impact of photodynamic treatment on S. aureus
mutagenesis.
Materials and methods
Strains and growth conditions The strains used in this study
are listed in Table 1. The S. aureus strains were grown in
brain-heart infusion broth (BHI media; BioMerieux, France).
For the strains carrying resistance genes, antibiotics were used
in overnight cultures at the following concentrations: erythro-
mycin, ERY (10 mg/l; Sigma-Aldrich, Germany), and chlor-
amphenicol, CHL (10 mg/l; Sigma-Aldrich, Germany). Bac-
teria from an overnight culture were diluted to an initial optical
density (OD) at 600 nm (OD600) of 0.1 in fresh medium and
grown with shaking (150 rpm) at 37 °C to the exponential
growth phase (OD600 0.6–0.7). Novobiocin (NOV) (Sigma-
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Aldrich, Germany) was added during the exponential growth
phase at concentrations related to the minimum inhibitory
concentration (MIC) of the strains (indicated in Table 1) and
incubated for 1 h with shaking (150 rpm) at 37 °C. The MIC
was determined as previously described (CLSI 2012).
Photosensitizers The following PSs were purchased from
Sigma-Aldrich (Germany): new methylene blue (NMB), tolu-
idine blue O (TBO), 5,10,15,20-tetrakis(1-methyl-4-
pyridinio)porphyrin tetra(p-toluenesulfonate) (TMPyP), zinc
phthalocyanine (ZnPc), and Rose Bengal (RB). Most of the
PSs, excluding ZnPc, were dissolved in distilled water to pro-
duce 1 or 0.1 mM stock solutions and stored in the dark at
−20 °C (1 mM for NMB, TBO, and TMPyP and 0.1 mM for
RB). ZnPc was dissolved in dimethyl sulfoxide (DMSO) to
obtain a 0.1 mM stock solution. The cationic C60 fullerene
derivative (fulleropyrrolidine, FUL) was purchased from
ProChimia (Poland). The compound was maintained in the
dark at a concentra t ion of 0.1 mM in dimethyl
sulfoxide:ddH2O solution (v/v, 1:9) (Grinholc et al. 2015).
Light sources Illumination was performed using the follow-
ing light sources: Q.Light® PDT Lamp (b & p® Schweiz AG,
Switzerland) (ISO 9001& EN 46001 - CE 1275) (lamp power
of 80 mW). The Q.Light® PDT Lamp emits polarized light
(polarization level 98 %) over a wavelength ranging from 620
to 780 nm (red filter, irradiance 102 mW/cm2), 385–480 nm
(blue filter, irradiance 127 mW/cm2), and white light (no filter
used, irradiance 267 mW/cm2). The LED illuminators had
wavelengths of 627 nm (light wavelength 627 nm, power
50 W, irradiance set at 11 mW/cm2) and 405 nm (light wave-
length 405 nm, power 120W, irradiance set at 5 mW/cm2) and
were custom designed for laboratory use (SecureMedia, Po-
land). The delivered light energy was determined with the use
of a light power meter (model LM2, CARL ZEISS,
Germany).
Photoinactivation Microbial overnight cultures were diluted
with fresh medium to an optical density OD600 of 0.1 and
cultured to exponential growth phase (OD600 0.6–0.7) with
shaking (150 rpm) at 37 °C. In the novobiocin-treated sam-
ples, the cultures were incubated for an additional 1 h with
MIC concentration of novobiocin (150 rpm, 37 °C). The cul-
tures were centrifuged (1000g) for 3 min, washed twice with
PBS, and resuspended in fresh BHI medium, and the concen-
tration was adjusted to 107 CFU/ml. The bacterial suspensions
were administered with PSs and incubated for 30 min at room
temperature in the dark (all PSs and their concentrations used
in this study are listed in Table 2). A 100 μl aliquot of the cell
suspension were transferred to a 96-well plate. The highest
concentration of DMSO used was below 0.1 % and was not
toxic to the cells. Cells were then illuminated with the appro-
priate light dose (characteristic of the light sources and applied
light doses are listed in Table 2). At the completion of the
Table 1 Strains used in this study
Strain Description, MIC Source
USA300 JE2 CA-MRSA USA300 JE2 strain, derived from USA300 LAC,
NOV (0.06 mg/L), CIP (32 mg/L), RIF (0.06 mg/L)
NARSA
NE805 Mutant derived from USA300 JE2 strain deposited in Nebraska
Transposon Mutant Library (NTML) with disrupted recA
(recombinase A) gene by bursa aurealis Tn insertion, NOV
(0.06 mg/L), CIP (32 mg/L)
NARSA
NCTC8325-4 Genome-sequenced laboratory strain, rsbU−, NOV (0.06 mg/L) (Novick 1967)
HG001 rsbU restored NCTC8325, NOV (0.5 mg/L) (Herbert et al. 2010)
HG001 recA HG001 with integrated pCG235 (recA PMUTIN), recA disrupted,
cultured in the presence of ERY (10 mg/L), NOV (0.25 mg/L),
CIP (0.06 mg/L)
(Schroder et al. 2013)
HG001 lexAG94E HG001 with G94E substitution in the LexA, uncleavable LexA,
NOV (0.5 mg/L)
(Schroder et al. 2013)
HG001 nov142 HG001 nov (gyrB142), NOV resistant derivative of HG001 (Schroder et al. 2014)
RN4220 recA-lux The recA promoter-lux fusion construct of the restriction-deficient
derivative of 8325-4 (RN4220), cultured in the presence of CHL
(10 mg/L)
(Mesak et al. 2008)
RN4220 lexA-lux The lexA promoter-lux fusion construct of the restriction-deficient
derivative of 8325-4 (RN4220), cultured in the presence of CHL
(10 mg/L)
(Mesak et al. 2008)
8325-4 hemB Isogenic strain derived from 8325-4, hemB knockout mutant displaying
the small colony variant (SCV) phenotype
(Von et al. 1997)
CHL chloramphenicol, NOV novobiocin, CIP ciprofloxacin, RIF rifampicin
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illumination period, 10-μl aliquots were removed from the
illuminated and non-illuminated wells (control cells were
maintained in 96-well plates covered with aluminum foil at
room temperature for the duration of the illumination) and
serially diluted tenfold in PBS to generate dilutions of 10−1
to 10−4 times the original concentrations. Afterward, 10-μl
aliquots of each dilution were streaked horizontally on square
Petri dishes containing brain-heart infusion medium (BHI;
BioMerieux, France) (Jett et al. 1997). The plates were
streaked in triplicate and incubated for 24 h at 37 °C in the
dark to allow colony formation. Controls groups included
cells that were not treated with PSs or light and cells that were
treated with light but not with PSs. In addition, control sam-
ples consisted of cultures that were treated with novobiocin
but kept in the dark. The survival fractions (SF) are expressed
as ratios of the CFU of microbial cells treated with
photoinactivation to the CFU of non-treated microbes. Each
experiment was performed three times for statistical analysis.
Photo-inducedDNA damage assay The cell suspension of
S. aureus in mid-log growth phase in PBS was treated
photodynamically as indicated in Table 2. Post-irradia-
tion, the genomic DNA (10 ng) was extracted from the
S. aureus cells using the ExtractME DNA Bacteria pu-
rification kit (Blirt S.A., Poland) and treated with Endo-
nuclease III (BioLabs, New England). This treatment
allows the visualization of the photo-induced damage
in the genomic DNA. The genomic DNA samples were
analyzed by electrophoresis (0.8 % agarose gel, with
ethidium bromide staining at 120 V). Band intensities
were measured as a percentage of the control sample
using ImageJ 1.48v (Wayne Rasband, National Institutes
of Health, USA; http://imagej.nih.gov/ij).
Western blot analysis The S. aureus strains were grown to
an OD600 of 0.6 and challenged with photoinactivation
and/or antibiotics (NOV and CIP) for 1 h (Tables 1 and
2). Three milliliters of the bacterial suspensions were har-
vested, washed with 5 ml Tris/EDTA (TE; 10 mM Tris,
1 mM EDTA, pH 7.4) and resuspended in 250 μl TE with
protease inhibitor cocktail as recommended by the manu-
facturer (Roche, Germany). After incubation on ice for
10 min, the cells were lysed with 0.25 ml of zirconia beads
(0.1 mm in diameter) in a high-speed homogenizer (Roche
MagNA Lyser) twice for 20 s each at a speed of 6500 rpm.
After centrifugation for 10 min at 4700g, the supernatant
was transferred and again centrifuged for 10 min at 13,
000g. The protein concentrations were determined in the
bacterial cell lysates using the Bio-Rad Protein Assay Dye
Reagent (Bio-Rad, Germany). Equal protein concentra-
tions (10 μg) were subjected to SDS-PAGE, and the sep-
arated proteins were transferred to a nitrocellulose blotting
membrane (GE Healthcare, Life Sciences, Germany)
using a Bio-Rad Mini Trans-Blot cell. The membrane
was blocked at room temperature for 1 h with 5 % non-
fat dry milk in PBS, pH 7.5. For immunostaining, poly-
clonal rabbit RecA antibodies (Abnova, Taiwan; 1:1000)
were used for an overnight incubation (4 °C). This was
followed by a 1-h incubation with secondary horseradish
peroxidase (HRP)-conjugated anti-rabbit IgG antibodies
(Cell Signaling, Germany; 1:2000) and detection of pro-
teins by enhanced chemiluminescence (ChemiDoc, Bio-
Rad) with a HRP substrate (SuperSignal, Thermo Scien-
tific, Germany).
Cell membrane integrity For the cell membrane studies, S.
aureus in mid-log growth phase was centrifuged (1000g,
3 min), washed, and resuspended in PBS, and then it was
Table 2 Sublethal (<2 log10 unit
reduction in viable counts) doses
of phototreatment
Sensitizer, concentration (μM) Light source Log10 reduction
NMB, 50 LED illuminators 627 nm, irradiance 11 mW/cm2,
fluence 50 J/cm2
0.45
TBO, 100 LED illuminators 627 nm, irradiance 11 mW/cm2,
fluence 50 J/cm2
0.7
TMPyP, 100 LED illuminators 627 nm, irradiance 11 mW/cm2,
fluence 50 J/cm2
0.5
ZnPc, 5 Q.Light® PDT Lamp 620–780 nm (red filter),
irradiance 102 mW/cm2, fluence 100 J/cm2
0.6
RB, 5 Q.Light® PDT Lamp 385–480 nm (blue filter),
irradiance 127 mW/cm2, fluence 200 J/cm2
1.0
FUL, 1 Q.Light® PDT Lamp white light (no filter used),
irradiance 267 mW/cm2, fluence 80 J/cm2
0.9





NMB new methylene blue, TBO toluidine blue O, TMPyP 5,10,15,20-tetrakis(1-methyl-4-pyridinio)porphyrin
tetra(p-toluenesulfonate), ZnPc zinc phthalocyanine, RB Rose Bengal, FUL fulleropyrrolidine
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exposed to 405-nm irradiation or control conditions (main-
tained in the dark). Additionally, untreated bacteria were
exposed to 0.01 % benzethonium chloride (BCl; cell mem-
brane disruption, positive control) for 1 h. Then, propidium
iodide (PI; at a final concentration of 5 μg/ml) was placed in
each sample, and the cells were incubated for an additional
30 min in the dark at room temperature. Following staining,
the bacteria were centrifuged, washed, and resuspended in
1-ml PBS. The fluorescence of the samples was read using
an EnVision Multilabel Plate Reader (PerkinElmer) with
488/570 nm excitation and emission filters. Additionally,
the samples were stained with SYTOX Green (Molecular
Probes) at a final concentration of 5 μM for 10 min at room
temperature. Finally, the fluorescence signal of DNA-bound
SYTOX Green was measured using an EnVision Multilabel
Plate Reader (Perkin Elmer) with 504/523 nm excitation
and emission filters. The experiments were performed three
times and analyzed statistically (Connell et al. 2013).
Rifampicin mutation frequency determinations The muta-
tion frequencies were determined as previously described
(O’Neill et al. 2001). Bacterial suspensions in mid-log
phase, after photodynamic treatment, were spread onto se-
lective BHI plates containing 4× MIC of rifampicin to re-
cover spontaneous antibiotic-resistant mutants. The culture
dilutions were also spread onto non-selective BHI to deter-
mine the viable cell numbers. The agar plates were incubat-
ed for 24–48 h at 37 °C, and the mutation frequencies are
expressed as the number of antibiotic-resistant mutants re-
covered as a proportion of the total cell count. The mutation
frequencies were determined for three biological replicates.
Ames mutagenicity assay The histidine-dependent (His−)
Salmonella enterica serovar Typhimurium (S. Typhimurium)
TA98 strain and pooled S9 enzymatic fraction from rat liver
induced with Aroclor (stored at −80 °C) were purchased from
Xenometrics (Stilwell, USA). The S9 fraction was mixed with
cofactors at a volume ratio of 1:24. The cofactors for the S9
mixture contained 19 mM MgCl2, 36 mM KCl, 4.5 mM
NADP, and 5.2 mM D-glucose-6-phosphate in 0.1 M sodium
phosphate buffer (pH 7.4). The Salmonella mutagenicity as-
say (Ames test) was conducted with preincubation as de-
scribed previously (Mortelmans and Zeiger 2000) with mod-
ifications. For the metabolic activation assay, 50 μl of the
overnight culture (cultivated for 4 h at room temperature and
then for 12 h at 37 °C with shaking) were incubated with
133 μl of S9 mix and 50 μl of the tested chemical for
20 min at 37 °C. Next, 67 μl of solution containing 0.1 μmol
of histidine and 0.1 μmol of biotin was added to the mixture,
which was then plated on the agar plate with minimal glucose
medium, as previously described (Woziwodzka et al. 2013).
For the assays conducted without metabolic activation, a pre-
viously reported procedure was used (Golunski et al. 2013;
Woziwodzka et al. 2011). A mixture containing 50 μl of the
overnight culture (cultivated for 4 h at room temperature and
then for 12 h at 37 °C with shaking), 60 μl of 3 % NaCl, and
150 μl of the tested chemical was incubated with shaking for
4 h at 37 °C. After incubation, the mixture was centrifuged,
and the bacteria were washed and resuspended in 300 μl of
0.6 % NaCl plating solution containing 0.1 μmol of histidine
and 0.1 μmol of biotin. Finally, the bacteria were plated on an
agar plate containing minimal glucose medium. The plates
were incubated for 48 h at 37 °C in the dark, and then the
His+ revertants were counted. All of the experiments were
performed in triplicate. The cytotoxic effects on the bacteria
were determined by observing the background lawn. For the
negative control, the tested chemical was replaced with dis-
tilled water. All of the results are presented as a percentage of
the mutagenic activity of the positive control. The results of
Ames test were evaluated statistically using Statistica 9.1
(StatSoft) software. One-way analysis of variance (ANOVA)
followed by the post-hoc RIR Tukey’s test was applied to
evaluate the results. The significance level was established at
α = 0.05.
Luminescence measurements Liquid assays were performed
at room temperature in a clear-bottom 96-well plate by using
starting cultures with an optical density at 595 nm of 0.15. The
bacteria were treated photodynamically or with ciprofloxacin,
and the luminescence was recorded every 2 h for 6 h in a
Wallac 1420 Victor multilabel counter (Perkin-Elmer). Each
determination was replicated three times.
Porphyrin extraction and fluorescence measurements It
was possible to detect the produced porphyrins based on their
extraction with MeOH:acetone (1:1, v/v). Extracellular porphy-
rins, which were excreted from the cells, were extracted from the
growth medium supernatant after lyophilization (Thermo Elec-
tron Corporation, Heto PowerDry LL3000 Freeze Dryer) and
sonication (Polsonic, Sonic-5) (10 min). After extraction of the
porphyrins, their fluorescence spectra were determined using a
Perkin Elmer Multimode Plate Reader EnVision® spectrofluo-
rometer. The excitation wavelength was 405 nm. To induce en-
dogenous porphyrin production, delta-aminolevulinic acid
(1 mM) was added to the bacterial suspensions and cultured for
48 h at 37 °C with shaking (150 rpm).
Statistical methods The means of the survival and biolumi-
nescence fractions were analyzed by one-way ANOVA. p-
values less than 0.05 were considered significant.
Results
Phototreatment leads to DNA damage Photoinactivation
induce DNA damage via the direct interaction between
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excited sensitizer molecules with DNA, by reactive ox-
ygen species-mediated reactions, or reactions involving
other secondary intermediates (Epe 2012). However, it
is accepted that this effect might only be observed in
largely photo-induced bacterial cells. Thus, we investi-
gated whether DNA damage could be detected using
sublethal photoinactivation (resulting in <2 log10 unit
reduction). Upon administration of the sensitizer and
sample irradiation, the S. aureus USA300 JE2 genomic
DNA was extracted, treated with endonuclease III, and
resolved by agarose gel electrophoresis (Fig. 1). As
shown in Fig. 1a, excluding fulleropyrrolidine-mediated
treatment, exogenous administration of the sensitizer up-
on irradiation resulted in significant DNA damage indi-
cated by the presence of DNA smear. Additionally, the
DNA damage was semi-quantified using ImageJ soft-
ware and presented as band intensities according to the
control samples. In the case of PDI-treated samples, the
control consisted of S. aureus cultures treated with
fulleropyrrolidine as previous studies indicated that this
sensitizer do not lead to DNA damage (Grinholc et al. 2015).
The same effect could also be observed with light treatment at
405 nm involving endogenously produced sensitizers
(Fig. 1b). However, no DNA damage was reported in control
samples consisting of S. aureus cultures treated with white,
red, and wide range blue light or with sensitizers without light
activation (Fig. 1c). The occurrence of DNA damage follow-
ing phototreatment within viable cells was also confirmed
using cell membrane integrity measurements. Blue light
(405 nm) doses up to 40 J/cm2 resulted in a large amount of
DNA damage (Fig. 1), but simultaneously, no disruption of
the cell membrane integrity was detected in the phototreated
cells (Fig. 2), which indicated that the majority of the bacterial
population was still viable.
RecA contributes to the phototreatment outcome Since
DNA damage could be observed in response to
phototreatment, one could assume that it promotes DNA
repair mechanisms and leads to the induction of the SOS
response, resulting in RecA activation. Thus, we investigat-
ed whether the presence of RecA or inhibition of the recA
gene could influence the efficacy of the phototreatment.
The wild-type USA300 JE2 and its isogenic daughter iso-
late JE2 recA (recA-negative, NE805) were treated by sub-
lethal photoinactivation (Fig. 3). In addition, the wild-type
strain was photoinactivated in the presence of MIC of
Fig. 1 Agarose gel electrophoresis showing the genomic DNA of
untreated and treated samples. a Genomic DNA damage of S. aureus
USA300 JE2 treated photodynamically according to Table 2 with NMB
(lane 1), TBO (lane 2), TMPyP (lane 3), ZnPc (lane 4), RB (lane 5), and
FUL (lane 6). Band intensity measured as a percentage of the control
(bacteria treated with FUL). b Genomic DNA damage of S. aureus
USA300 JE2 treated with light at 405 nm: lane 1: non-treatment control
(bacteria kept in dark); lanes 2–5: phototreated bacteria (10, 20, 30, and
40 J/cm2). Band intensity measured as a percentage of the control
(bacteria kept in dark). c Genomic DNA damage of S. aureus USA300
JE2 treatedwith control conditions: lane 1: bacteria kept in the dark; lanes
2–7: bacteria treated with sensitizers in the dark (NMB, TBO, TMPyP,
ZnPc, RB, and FUL, respectively); lanes 8–11: bacteria treated with light
(627 nm, irradiance 11 mW/cm2, fluence 50 J/cm2; 620–780 nm (red
filter), irradiance 102 mW/cm2, fluence 100 J/cm2; 385–480 nm (blue
filter), irradiance 127 mW/cm2, fluence 200 J/cm2; white light (no filter
used), irradiance 267 mW/cm2, fluence 80 J/cm2). Band intensity
measured as a percentage of the control (bacteria kept in dark)
9166 Appl Microbiol Biotechnol (2015) 99:9161–9176
novobiocin (recA-downregulating agent) (Fig. 3). The bac-
tericidal effectiveness against these S. aureus strains was
also analyzed using the 405-nm light treatment (Fig. 4).
As indicated, the strain with disrupted (JE2 recA) or
inhibited (novobiocin) recA expression demonstrated in-
c r e a s e d s u s c e p t i b i l i t y t o PD I , e x c l u d i n g t h e
fulleropyrrolidine treatment. This result suggests that
DNA damage occurs in phototreated cells and that the dam-
age can be counteracted by RecA activity. Thus, the inhibi-
tion of recA expression as part of DNA repair mechanisms/
SOS response system could increase the bactericidal effica-
cy of the PDI.
The effect of novobiocin on the phototreatment efficacy is
due to recA repression that mediated by GyrB-dependent
inhibition We have previously shown that novobiocin
downregulates the transcription of recA (Schroder et al.
2013; Mesak et al. 2008), and this effect is mediated by inhi-
bition of the GyrB subunit (Schroder et al. 2014). To verify
that the presence of novobiocin did not influence the
phototreatment outcome via the GyrB-independent pathway,
the bactericidal effectiveness of the photoinactivation was
analyzed for the wild-type S. aureus strain (HG001) and its
isogenic mutant strain expressing a novobiocin non-
susceptible GyrB enzyme (HG001 nov142). This latter strain
is resistant to novobiocin. To simplify the analysis, the indi-
cated strains were treated only with the 405-nm light, and it
was assumed that a similar effect would be observed for ex-
ogenously administered sensitizers. This assumption was war-
ranted by the similar DNA damage upon photoinactivation
and its recA-dependent efficacy. The parental strain revealed
increased susceptibility to photodynamic treatment in the
presence of novobiocin (Fig. 5). In the novobiocin-resistant
strain, the effectiveness of 405-nm irradiation was comparable
to that observed in the parental strain and was not affected by
the presence of novobiocin. The results clearly indicate that
the effect of novobiocin on the phototreatment efficacy is
mediated by GyrB and is unlikely to be due to additional
effects on other potential targets.
Phototreatment increases recA expression Because
phototreatment induced DNA damage (Fig. 1), and its
efficacy depended on RecA level (Figs. 3 and 4), this
treatment should also result in increased recA expres-
sion. To analyze the effects of antibiotics (CIP and
NOV) and phototreatment on RecA expression, both
factors were applied to exponentially growing bacteria,
and the levels of RecA protein were determined using
immunoblotting of lysates from bacteria treated with or
without antibiotics and/or photoinactivation. We primar-
ily verified whether the S. aureus strains used herein
expressed previously described levels of RecA and
responded accordingly to the proposed mechanism of
NOV and CIP. Ciprofloxacin is a well-known RecA-in-
ducing agent and was used as a positive control for
increased RecA expression (Schroder et al. 2013). The
wild-type USA300 JE2 strain responded adequately to
the administered antibiotics (increased RecA upon cip-
rofloxacin and reduced RecA upon novobiocin treat-
ment) (Fig. 6a). Both S. aureus mutant strains contain-
ing a disruption of the recA gene exhibited low expres-
sion level of RecA (Fig. 6a). Finally, the strain express-
ing a GyrB enzyme that is not susceptible to novobiocin
(HG001 nov142) showed no reduction of RecA in re-
sponse to novobiocin treatment (Fig. 6a). We also veri-
fied that at sublethal doses of phototreatments in the
presence of photosensitizer, the levels of RecA protein
increased (Fig. 6b) except fulleropyrrolidine treatment.
To verify that the expression of recA was also increased
at the mRNA level, the recA promoter-lux constructs
were used to enable the monitoring of increased gene
expression by measuring the luminescence (Mesak et al.
2008). The starting cultures of S. aureus with an optical
density at 595 nm of 0.150 were treated photodynami-
ca l ly or wi th CIP (pos i t ive cont ro l ) , and the
Fig. 2 S. aureus cell membrane integrity. a Total SYTOX Green
fluorescence readings for different groups. b Total propidium iodide
fluorescence readings for different groups. All of the groups were
statistically significant compared with the negative and positive control.
All of the values were normalized with respect to the same bacterial
populations treated for 1 h with BCl (0.01 %). Significance of
comparisons between treated samples and control, p < 0.0001
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luminescence of the samples was recorded every 2 h
(Fig. 7a). The results of luminescence assays were in
ag r eemen t w i th Wes t e rn b lo t ana ly s i s . Each
photosensitizer treatment, excluding fulleropyrrolidine,
increased in the bioluminescence signal indicating in-
duction of recA expression (Fig. 7a).
Fig. 3 Photoinactivation efficacy against S. aureus USA300 JE2.
Microbial cell planktonic suspensions of S. aureus USA300 JE2 (white
bars) and JE2 recA (gray bars) in mid-log phase were incubated for
30 min with various sensitizers and then illuminated in accordance with
the conditions presented in Table 2. For the novobiocin-mediated
experiments (black bars), mid-log phase cultures were preincubated
with antibiotic (MIC) for 1 h at 37 °C. The values are means of three
separate experiments, and the bars represent S.D. Significance of
comparisons between novobiocin-treated samples and control, p < 0.01.
Significance of comparisons between JE2 recA and wild-type strain,
p < 0.01. NMB new methylene blue, TBO toluidine blue O, TMPyP
5,10,15,20-tetrakis(1-methyl-4-pyridinio)porphyrin tetra(p-
toluenesulfonate), ZnPc zinc phthalocyanine, RB Rose Bengal, FUL
fulleropyrrolidine, NOV, novobiocin
Fig. 4 Blue light (405 nm)
irradiation efficacy. Microbial cell
planktonic suspensions of S.
aureus USA300 JE2 (black
diamonds) and JE2 recA (open
squares) in mid-log phase were
illuminated with blue light
(405 nm) within a range of
irradiances (0–50 J/cm2). For the
novobiocin-mediated
experiments (black triangles),
mid-log phase cultures were
preincubated with antibiotic
(MIC) for 1 h at 37 °C. The values
represent the means of three
separate experiments, and the
bars are the S.D. Significance of
comparisons to the control,
*p < 0.05, **p < 0.01. NOV
novobiocin
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RecAdetermines the response of S. aureus to phototreatment
independent to LexA Induction of ssDNA formation during
phototreatment may increase RecA level. RecA interacts and
promotes the self-cleavage of LexA leading to the derepres-
sion of recA and other SOS response genes. By using lumi-
nescence assay in lexA-lux and recA-lux strains, we showed
both lexA and recA expression induced by phototreatments
(Fig. 7).To investigate the role of RecA alone without inter-
ference from LexA, we used the S. aureus strain with
uncleavable LexA (HG001 lexAG94E). We found the re-
sponse of HG001 lexAG94E to photoinactivation was not sig-
nificantly different from the wild-type strain (Fig. 5).
Blue light (405 nm) treatment is dependent on endogenous
porphyrins Because the major mechanistic studies in the cur-
rent work were conducted with blue light (405 nm) treatment,
we verified whether the underlying mechanism of the bacteri-
cidal activity of blue light (405 nm) included endogenously
produced photosensitizers or other factors that are involved in
its antibacterial activity. To address this question, we used the
S. aureus wild-type reference strain (NCTC 8325-4), which is
capable of endogenous porphyrin production, and its isogenic
knockout mutant (8325-4 ΔhemB), displaying a stable, elec-
tron transport-deficient small colony variant (SCV) phenotype
(Von et al. 1997). hemB is a part of the porphyrin biosynthetic
pathway encoding the aminolevulinic acid dehydrase
(porphobilinogen synthase) (Granick and Beale 1978). Be-
sides slow growth, SCVs are characterized by many common
features such as reduced pigmentation and metabolic changes
(Kriegeskorte et al. 2014). The lack of the ability to produce
endogenous porphyrins was determined spectrophotometri-
cally by fluorescence measurements of S. aureus culture
Fig. 5 Photoinactivation efficacy
against S. aureus HG001.
Microbial cell planktonic
suspensions of S. aureus HG001,
HG001 nov142, HG001 recA,
and HG001 lexA in mid-log phase
were illuminated (405 nm,
irradiance 5 mW/cm2, fluence
10 J/cm2). For the novobiocin-
mediated experiments, mid-log
phase cultures were preincubated
with antibiotic (MIC) for 1 h at
37 °C. The means of three
separate experiments are
presented, and the bars represent
the S.D. Significance of
comparisons to the control,
*p < 0.05, **p < 0.01. NOV
novobiocin
Fig. 6 Effects of novobiocin/ciprofloxacin and phototreatments on RecA
expression. The RecA protein level was detected by Western blot
analysis. S. aureus strains were grown to exponential phase (OD600 0.6)
and treated with or without ciprofloxacin (CIP) and novobiocin (NOV)
for 1 h. a Effects of the antibiotics on RecA level. b Effects of the
phototreatments on the RecA level
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supernatants after excitation with light wavelengths of
405 nm. To induce endogenous porphyrin production, the S.
aureus cultures were exposed to delta-aminolevulinic acid. As
shown in Fig. 8, only the wild-type strain was able to produce
endogenous porphyrins, as indicated by the specific fluores-
cence peaks at 580 and 630 nm. To determine whether this
ability is required for the bactericidal activity of blue light
(405 nm), the light treatment was applied to the hemB mutant
and parental strain (Fig. 9). As expected, exposure of the wild-
type S. aureus strain to light treatment resulted in a greater
reduction of viable cells when the cells were preincubated
with novobiocin. In contrast to these findings, the hemB mu-
tant strain displayed no decrease in viability following irradi-
ation, supporting the requirement for endogenously produced
porphyrins to produce the bactericidal activity of the 405-nm
light treatment (Fig. 9).
Phototreatment does not contribute to the increased S.
aureus mutability Previous studies have suggested that oxi-
dative stress might prompt genotypic variation among bacte-
rial species (Boles and Singh 2008). Phototreatment causes
DNA damage and RecA activation, and one can assume that
the SOS response could also be induced. This event leads to
DNA repair and might result in an increased mutation fre-
quency through the induction of error-prone polymerases such
as Umu (Cirz et al. 2007). Because the error-prone polymerase
UmuC plays a key role in accelerating the mutation frequency,
we determined the influence of phototreatment on the devel-
opment of spontaneous resistance to rifampicin. To investigate
whether photo-induced oxidative stress might increase the
mutability of S. aureus, we examined the effects on mutation
frequencies in response to antibiotic treatment using a 4×MIC
rifampicin concentration in culture medium. Planktonic S.
aureus USA300 JE2 did not demonstrate significant differ-
ences in mutation frequency in response to phototreatment
in comparison to basal mutation frequencies (Fig. 10).
Fig. 7 Expression of SOS genes. The luminescence of a S. aureus
RN4220 recA-lux and b RN4220 lexA-lux treated with ciprofloxacin
(CIP) or photoinactivating conditions in broth was measured using a
Wallac 1420 Victor multilabel counter (Perkin-Elmer). The control
consisted of bacteria that were maintained in the dark. The means of
three separate experiments are shown, and the bars represent the S.D.
Fig. 8 Fluorescence emission
spectra of ALA-induced
porphyrins in S. aureus
NCTC8325-4. The bacteria were
incubated with 1 mM ALA for
48 h (37 °C, 150 rpm). Next,
extracellular porphyrins were
extracted from the growth
medium supernatant after
lyophilization and sonication
(10 min). After extraction of the
porphyrins, their fluorescence
spectra were determined using a
Perkin Elmer EnVision
spectrofluorometer, with an
excitation wavelength of 405 nm
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Ames mutagenicity assay We used the S. Typhimurium
TA98 strain to investigate the mutagenic activity of photosen-
sitizers (without light activation), light doses, and photody-
namic treatment (photo-induced sensitizers), both without
and with the activating microsomal S9 fraction (Fig. 11).
The mutagenic effects of sensitizers that were not activated
are shown in Fig. 11a, b. All of the analyzed compounds were
non-mutagenic against bacterial cells in the absence and pres-
ence of the S9 fraction. The exposition of bacterial cells to
light doses used for sensitizer activation revealed no
mutagenic activity of the light alone (Fig. 11c). Finally, no
mutagenic activity was reported for the phototreatments ex-
amined herein (sensitizers/light combinations) (Fig. 11d).
However, regarding NMB, TBO, and TMPyP, the analyzed
treatment conditions were cytotoxic to the S. Typhimurium
strain, and its mutagenic activity could not be determined
properly (Fig. 11d). A high level of cytotoxicity was also
detected for TBO without light activation (Fig. 11a).
Discussion
It is generally accepted that DNA damage occurs when cells
are intensively photoinactivated or are no longer viable (Alves
et al. 2014). Data published by George and Kishen (2008)
based on a DNA damage s tudy ind i ca t ed tha t
photoinactivation using methylene blue (MB) could cause ex-
tensive damage to the chromosomal DNA of Enterococcus
faecalis cells when more than 3 log10 unit reduction in cell
concentration was obtained. Because a close association be-
tween the photosensitizer and the target is required to cause
the deleterious effect, the data indicated that MB molecules
can penetrate the cell wall of bacteria and damaged their
chromosomal DNA. However, when MB was applied in
doses that only reduced less than 2 log10 bacterial cells, the
DNA damage was considerably lower. Similar results were
obtained by Caminos et al. (2008) in their studies of
Escherichia coli photosensitization with TMPyP. Significant
damage of genomic DNA has been reported in studies of
photodynamic treatment’s doses that kill bacterial cells for
more than 2 log10 unit reduction (Caminos et al. 2008). The
same effect was observed for zinc phthalocyanine (ZnPc) by
Spesia et al. (2009) (Spesia et al. 2009). Therefore, the role of
Fig. 9 Photoinactivation efficacy against S. aureus NCTC8325-4.
Microbial cell planktonic suspensions of S. aureus NCTC8325-4 and
the ΔhemB mutant in mid-log phase were illuminated (405 nm,
irradiance 5 mW/cm2, fluence 10 J/cm2). For the novobiocin-mediated
experiments, mid-log phase cultures were preincubated with antibiotic
(MIC) for 1 h at 37 °C. Values represent the means of three separate
experiments and bars represent the S.D. Significance of comparisons to
the control, *p < 0.05. NOV novobiocin
Fig. 10 Effect of
phototreatments on the
development of resistance. S.
aureus USA300 JE2 cultures in
mid-log phase were treated
photodynamically and plated on
BHI plates as well as plates
supplemented with rifampicin
(0.25 mg/l) to determine the
mutation frequency. The mutation
frequency was defined as the ratio
of resistant colonies in relation to
the total number of bacteria
(CFU). The bars represent the
mean values of three biological
replicates + S.D.
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DNA as a target in the photodynamic process that influences
cell viability has been underestimated, and membrane proteins
are considered to be major targets of photo-induced oxidation.
In the present work, in agreement with a thesis that cell enve-
lopes are the major targets of photoinactivation, we attempted
to evaluate the actual contribution of DNA damage to the
outcome of phototreatment. The results indicate that photo-
induced DNA damage can occur in cells that are still viable or
when sublethal treatment was applied and less than 1–2 log10
cell reduction was detected (Fig. 1). Moreover, we showed
that DNA damage can be easily detected even without disrup-
tion of the cell membrane integrity (Fig. 2), which indicated
that if the DNA repair mechanism was activated during the
course of the photodynamic treatment, then the bacterium
could overcome the induced DNA damage and avoid inacti-
vation. In agreement with our previously published data, no
DNA damage was reported in fulleropyrrolidine-sensitized S.
aureus cells (Grinholc et al. 2015). This result was probably
due to the low cell-penetrating ability of the sensitizer. In the
case of fulleropyrrolidine treatment, a high level of cell enve-
lope integrity disruption has been reported in response to
activation with light, indicating that this compound binds to
the cell envelope and exerts its bactericidal activity in close
proximity (Grinholc et al. 2015).
For numerous bacteria, the SOS response has been recog-
nized as a critical factor in the response to stress, in particular
to induced damage to DNA, which is processed to single-
stranded DNA (Cirz et al. 2007). RecA forms filaments on
the single-stranded DNA, facilitating repair via recombination
and stimulating the autoproteolysis of the SOS gene repressor
LexA. This cleavage inactivates the LexA repressor and re-
sults in the induction of SOS genes. Many classes of antibi-
otics, including fluoroquinolones, e.g., ciprofloxacin, and β-
lactams, have been shown to induce LexA cleavage and the
SOS response via the upregulation of recA expression
(Schroder et al. 2013; Miller et al. 2004). LexA controls the
expression of recA and lexA, the positive and negative regu-
lators of the response, as well as genes encoding proteins
involved in DNA repair or recombination and the DNA poly-
merases required for the induced mutation (Cirz et al. 2007).
In addition, in previous studies, we confirmed the strong acti-
vation of recA expression by ciprofloxacin in S. aureus and
Fig. 11 Mutagenic activity of the analyzed photosensitizers and light in
the S. Typhimurium TA98 mutagenicity assay (Ames test). a Mutagenic
activity of analyzed photosensitizers in Ames test without mutagenic
activation. The results are reported as a percentage of the positive
control (doxorubicin, 90 ng per plate; 909 ± 72 (±SD) revertants per
plate) ± SD. b Mutagenic activity of the analyzed photosensitizers in
the Ames test with mutagenic activation. The results are reported as a
percentage of the positive control (2-amino-3-methylimidazo[4,5-
f]quinoline, 10 μg per plate; 4887 ± 432 (±SD) revertants per
plate) ± S.D. c Mutagenic activity of the analyzed light treatments in
the Ames test without mutagenic activity. The results are reported as the
percentage of the positive control (doxorubicin, 90 ng per plate; 325 ± 16
(±S.D.) revertants per plate) ± S.D. dMutagenic activity of the analyzed
photosensitizer-light combinations in the Ames test without mutagenic
activity. The results are reported as the percentage of the positive control
(doxorubicin, 90 ng per plate; 452 ± 14 (±S.D.) revertants per plate) ±
S.D.; ct observed cytotoxic effects
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subsequently demonstrated that aminocoumarins (novobiocin)
lead to the repression of recA expression (Schroder et al. 2013).
In the present work, we attempted to evaluate the significance
of photo-induced DNA damage by investigating the S. aureus
SOS pathway in response to emergent DNA breaks. The results
revealed that partial inhibition of the SOS machinery resulted
specifically from the downregulation of recA expression or dis-
ruption of the recA gene, and consequently, the efficacy of the
photodynamic treatment could be significantly enhanced
(Figs. 3, 4, and 5). This finding suggests that photoinactivation
results in severe DNA damage that leads to cell death if the
DNA repair systems are inhibited. Moreover, the induction of
DNA breaks in viable cells leads to increased levels of RecA
protein as well as upregulation of the recA gene (Figs. 6 and 7).
However, the observed phenomena were not reported for
fulleropyrrolidine because no DNA damage was detected fol-
lowing the administration of this compound (Fig. 1a) (Grinholc
et al. 2015). It is not likely that the increased susceptibility of S.
aureus to photoinactivation resulted solely from the downreg-
ulation of recA expression when administered with novobiocin.
Thus, the observed phenomenon was confirmed in a
novobiocin-resistant S. aureus mutant strain expressing a non-
susceptible GyrB enzyme (HG001 nov142). This strain showed
no reduction of RecA levels in response to treatment with no-
vobiocin (Fig. 6a), and as expected, no increased susceptibility
to phototreatment was observed (Fig. 5). This result indicates
that the effect of novobiocin on the phototreatment efficacy is
mediated by antibiotic-dependent GyrB inhibition and is un-
likely to be due to additional effects on other potential targets.
These findings could be translated into clinical value because
the use of recA downregulating agents could provide increased
bactericidal activity during photodynamic treatment for both
exogenously administered sensitizers (Fig. 3) and endogenous
porphyrins (blue light treatment) (Figs. 4, 5, and 9).
The recA gene is preceded by a LexA-binding motif, and
thus, the upregulation of recA in response to phototreatment
presumably occurs through LexA cleavage. Thus, we utilized
a previously constructed mutant in which LexAwas rendered
uncleavable (Schroder et al. 2013). In a previous study, we
showed that the basal level of recA in untreated S. aureus
cultures was not significantly different between wild-type
and the lexAG94Emutant (Schroder et al. 2013). Furthermore,
as expected, the addition of ciprofloxacin did not result in
enhanced recA transcription in lexAG94E indicating that recA
expression could not be upregulated in this strain (Schroder
et al. 2013). The response of HG001 lexAG94E to
photoinactivation was not significantly different when com-
pared to the wild-type strain, which indicated that the basal
level of RecAwas sufficient to determine the susceptibility of
S. aureus to the photo-mediated treatments (Fig. 5). Our re-
sults indicate that RecA activity, and no other LexA target
genes, is needed for bacterial response to photoinactivation.
This is in line with our next observation that the mutation
frequencies are not altered because umuC is probably not
expressed. This result suggests that the mechanism employed
to potentiate the bactericidal efficacy of photoinactivation re-
sides in the inhibition of recA prior to irradiation (i.e., in re-
sponse to novobiocin pretreatment).
The mutation plays an important role in the development of
antibiotic resistance in S. aureus and other staphylococci
(Woodford and Ellington 2007). A single point mutation can
cause clinically significant levels of resistance to a variety of
antimicrobials, such as rifampicin, mupirocin, fusidic acid,
and fluoroquinolones. Moreover, in cases of the accumulation
of mutations at multiple loci, resistance to glycopeptides could
be achieved (Kato et al. 2010). Thus, the identification of any
factor that elevates the basal mutation frequency is a high
priority. Consequently, investigations to determine whether
the proposed treatment leads to the emergence of antibiotic
resistance are a key issue. In principle, the mutagenic activity
of antimicrobials is considered to occur within concentrations
that are very close to the MIC because higher concentrations
may have bactericidal effects and damage most of the cells in
the population. In contrast, lower concentrations do not pro-
vide a stimulatory effect (Couce and Blazquez 2009). Thus, in
the current work, we investigated the mutagenic effect of
phototreatments at sublethal doses (reducing cell viability by
<2 log10 units) by evaluating the appearance of mutants car-
rying resistance to rifampicin. Here, we showed that, although
DNA damage and RecA activation could be observed,
photoinactivation did not increase the mutation frequency
(Fig. 10). This result is likely due to the lack of umuC activa-
tion, which represents induction of the late SOS response, and
a phototreatment exposure duration of several minutes (in
recent studies, the longest phototreatment exposure was
72 min). However, in the present study, the expression of
umuCwas not investigated, and thus, further studies are need-
ed. We also conducted the bacterial mutagenicity test (Ames
test) using one of the reference strains: S. Typhimurium TA98.
The Ames test is the standard mutagenicity test performed
prior to the introduction of new drug candidates (McCarren
et al. 2011). This test is accepted by numerous international
organizations and fulfills ISO guidelines (Reifferscheid et al.
2012). To be confirmed as non-mutagenic, the drug candidate
must be analyzed using five reference strains—three in the
Salmonella genus and two in the Escherichia genus
(Mortelmans and Zeiger 2000); however, the analysis of one
strain is sufficient to describe the compound as non-mutagenic
and recommends further investigations, especially basic sci-
ence research. Very limited published data have assessed the
mutagenicity of phototreatments and related sensitizers. Thus,
the present findings provide a significant improvement of our
knowledge regarding photodynamic treatments. Casteel et al.
(2004) performed genotoxicity assays using a non-activated
sensitizer (without illumination) and showed that the revertant
counts did not increase in comparison to background levels,
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indicating that none of the studied porphyrins was mu-
tagenic in S. Typhimurium TA98 (Casteel et al. 2004).
The results presented herein indicate that the photosen-
sitizers assessed are non-mutagenic both without and
with metabolic activation. It is important to note that
although the analyzed compounds are applied to the
skin, they may be absorbed and transferred via the
blood to the liver, where they can undergo enzymatic
reactions catalyzed by cytochrome P450. Therefore, as-
sessments of the mutagenic activity using the S9 frac-
tion allowed us to reject the concept that this activity
might be exerted by metabolites of the compounds eval-
uated. In addition, although the S. Typhimurium TA98
strain is sensitive to light (especially UV light)
(Mortelmans and Zeiger 2000), treatment of the samples
with light did not produce any response, which would
have been observed as an increased number of His+
revertants. Unfortunately, in the cases utilizing new
methylene blue, toluidine blue O, which is also toxic
when tested without light and metabolic activation, and
TMPyP, the combination of light and photosensitizer
was toxic to the bacterial strain assessed (Fig. 11a, d).
However, the main purpose of therapy is to inhibit bac-
terial growth, and thus, these effects might be attributed
to the efficiency of the proposed combinations in killing
bacterial strains together with an increased susceptibility
to external factors. Nevertheless, to fully confirm the
non-mutagenic and non-toxic properties of the analyzed
photosensitizer-light combinations, they should be tested
both in other bacterial strains recommended for the
Ames test and eukaryotic cell lines. Finally, one must be con-
scious that the absence of an increased number of rifampicin-
resistant S. aureusmutants and of mutagenic activity toward S.
Typhimurium may also have resulted from the phototreatment
conditions and duration of exposure used in our experiments.
These variables may not have been capable of selecting for
Fig. 12 Proposed mechanism underlying the photoinactivation process.
Irradiated sensitizer molecules achieve an activated state and lead to the
production of reactive oxygen species as well as free radicals (oxidative
stress). This process results in cell membrane as well as DNA damage
(excluding the poor-cell-penetrating fulleropyrrolidine). The SOS
machinery is operated by two key regulators: the SOS repressor LexA
and the inducer RecA. RecA responds to DNA damage by binding to
ssDNA, which triggers autocleavage of LexA. The LexA repressor
dissociates from the SOS boxes and induces transcription of the SOS
regulon. Novobiocin binds to the GyrB subunit of gyrase and inhibits
transcription, leading to the decrease in recA expression. APDT
antimicrobial photodynamic therapy, PS photosensitizer, EndoPP
endogenous porphyrins, NMB new methylene blue, TBO toluidine blue
O, TMPyP 5,10,15,20-tetrakis(1-methyl-4-pyridinio)porphyrin tetra(p-
toluenesulfonate), ZnPc zinc phthalocyanine, RB Rose Bengal, FUL
fulleropyrrolidine
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rifampicin-resistant variants or His+ revertants, and further
studies examining a range of concentrations as well as a
prolonged duration of exposure should be considered.
In the present study, we aimed to investigate the mechanistic
features of the photoinactivation process. Our findings are sum-
marized in the Fig. 12, which shows the proposedmechanism of
photoinactivation involving the SOS machinery. Moreover, the
results of the present study, in comparison to previously pub-
lished data, provide strong evidence that the inactivation of bac-
teria using 405-nm light results from the photostimulation of
endogenous porphyrins. This study provides proof-of-concept
evidence that DNA damage is the significant factor triggered by
the photoinactivation process and also occurs in phototreated but
viable bacterial cells. If these cells are not treated with agents
that affect DNA repair mechanisms, then they would achieve a
harmless state and would not be inactivated. Thus, we explored
the effect of RecA inhibition on the efficacy of phototreatment.
Our results using the recA-defective strain and the application of
a recA-downregulating agent (novobiocin) suggest that the ef-
fectiveness of photoinactivation depends in part on RecA activ-
ity, thus supporting the hypothesis that RecA inhibition is a
potential therapeutic adjuvant in combination with photodynam-
ic approaches.
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